Valuation: Sopharma AD

Market Cap 1.93B 1.16B 1.01B 932M 869M 1.65B 111B 1.67B 11.19B 4.35B 54.32B 4.36B 4.26B 187B P/E 2024
12.3x
P/E 2025 7.16x
Enterprise Value 2.47B 1.49B 1.3B 1.19B 1.11B 2.11B 141B 2.14B 14.33B 5.57B 69.53B 5.58B 5.46B 240B EV / Sales 2024
0.66x
EV / Sales 2025 0.76x
Free-Float
31.06%
Yield 2024
2.68%
Yield 2025 -
1 day-1.03%
1 week-0.52%
Current month-0.52%
1 month-0.78%
3 months+9.71%
6 months+34.77%
Current year+34.77%
1 week 1.9
Extreme 1.895
1.94
1 month 1.86
Extreme 1.855
1.94
Current year 1.41
Extreme 1.41
2
1 year 1.2
Extreme 1.1987
2
3 years 0.89
Extreme 0.8858
2
5 years 0.57
Extreme 0.5729
2
10 years 0.41
Extreme 0.4087
2
Manager TitleAgeSince
Chief Executive Officer 42 01/10/2000
Director of Finance/CFO - 01/01/2002
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 42 19/05/2010
Director/Board Member - -
Director/Board Member 63 19/05/2010
Date Insider Type Main position Quantity % Market Cap.
30/09/20Buy

Chief Executive Officer

12,000 0.0089%
30/09/20
Donev Investments Ad
BuyCompany 25,489 0.0189%
29/09/20
Donev Investments Ad
BuyCompany 9,000 0.0067%
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%-0.52%+57.33%+110.94% 1.16B
+5.68%+12.88%-13.95%-28.51% 14.7B
+4.44%+7.17%-27.21%-31.32% 6.78B
+0.52%+0.80%-17.24%-11.46% 5.87B
+3.58%+9.79%-19.22%-34.38% 3.57B
+3.52%+7.91%-36.55%-9.06% 3.44B
0.00%-0.37%-28.20%-44.56% 3.25B
+4.67%+15.20%+0.53%-37.68% 2.86B
-0.31%-0.73%+101.44% - 2.66B
-0.34%-2.60%-1.21%+37.17% 1.72B
Average +2.07%+4.31%+1.57%-5.43% 4.6B
Weighted average by Cap. +3.31%+6.90%-9.58%-21.05%

Financials

2024 2025
Net sales 2.14B 1.28B 1.12B 1.03B 962M 1.83B 122B 1.85B 12.39B 4.82B 60.14B 4.82B 4.72B 207B 2.63B 1.58B 1.38B 1.27B 1.18B 2.25B 151B 2.28B 15.25B 5.93B 74B 5.94B 5.81B 255B
Net income 77.85M 46.75M 40.87M 37.56M 35.01M 66.41M 4.45B 67.42M 451M 175M 2.19B 175M 172M 7.54B 134M 80.19M 70.11M 64.43M 60.05M 114M 7.64B 116M 773M 301M 3.75B 301M 295M 12.93B
Net Debt 444M 267M 233M 214M 200M 379M 25.4B 385M 2.57B 1B 12.49B 1B 980M 43.03B 541M 325M 284M 261M 243M 462M 30.95B 469M 3.14B 1.22B 15.21B 1.22B 1.19B 52.43B
Logo Sopharma AD
Sopharma AD, formerly Sopharma AD Sofia, is a Bulgaria-based company engaged in the generic pharmaceutical industry. The Company specializes in the production and trade of medical substances and finished drug forms, as well as research and development in the field of medical products. Through the ampoule plant, tablet plant and the plant in Vrabevo it produces medicines, such as analgesics, antipyretics, cardiovascular medicines as well as drugs for respiratory disease treatment, among others. The Company offers its products under the brand Tribestan, Nivalin and Tabex, among others. In addition, it specializes in the gamma-sterilization of medical materials. It is the parent company of Sopharma Group and operates domestically and abroad in such countries as Russian Federation, Poland, Ukraine, Serbia, the United States and the United Kingdom, among others.
Employees
6,005
Date Price Change Volume
03/07/26 €1.920 -1.03% 1,166
02/07/26 €1.940 +0.52% 715
01/07/26 €1.930 0.00% 11,331
30/06/26 €1.930 0.00% 30,702
29/06/26 €1.930 0.00% 5,711

Annual profits - Rate of surprise